Role of RANKL in the regulation of NFATc1 and c‑Src mRNA expression in osteoclast‑like cells

Fu,Jifan; Tao,You Di; Chen,Jian; Zhang,Yongsheng; He,Jianquan

doi:10.3892/mmr.2016.5176

Role of RANKL in the regulation of NFATc1 and c‑Src mRNA expression in osteoclast‑like cells

Authors:
- Jifan Fu
- You Di Tao
- Jian Chen
- Yongsheng Zhang
- Jianquan He
View Affiliations

Affiliations: Department of Rehabilitation, Zhongshan Hospital of Xiamen University, Xiamen University, Xiamen, Fujian 361004, P.R. China
Published online on: April 25, 2016 https://doi.org/10.3892/mmr.2016.5176
Pages: 5163-5168

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study was designed to determine the effects of receptor activator of nuclear factor κB ligand (RANKL) on the mRNA expression of nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATc1) and c‑Src in rat osteoclast‑like cells. The marrow cells were exposed to macrophage colony-stimulating factor (M‑CSF; 25 ng/ml) and different concentrations of RANKL (0, 50, 75 and 100 ng/ml) for 9 days. The mRNA expression of NFATc1 and c‑Src was determined by polymerase chain reaction. Compared with the M‑CSF (25 ng/ml)+RANKL (0 ng/ml) group, the levels of NFATc1 and c‑Src mRNA expression were significantly increased in the M‑CSF (25 ng/ml)+RANKL (75 and 100 ng/ml) groups (P<0.01, P<0.01, P<0.01 and P<0.01, respectively). Compared with the M‑CSF (25 ng/ml)+RANKL (50 ng/ml) group, the levels of NFATc1 and c‑Src mRNA expression was significantly increased in the M‑CSF (25 ng/ml)+RANKL (75 and 100 ng/ml) groups (P<0.05, P<0.01, P<0.01 and P<0.01, respectively). Compared with M‑CSF (25 ng/ml)+RANKL (75 ng/ml) group, the levels of NFATc1 and c‑Src mRNA expression was significantly increased in the M‑CSF (25 ng/ml)+RANKL (100 ng/ml) group, (P<0.01 and P<0.01, respectively). These data suggest that RANKL could regulate the expression of NFATc1 and c‑Src mRNA in the marrow culture system.

View Figures

View References

1	Alliston T and Derynck R: Medicine: Interfering with bone remodelling. Nature. 416:686–687. 2002. View Article : Google Scholar : PubMed/NCBI
2	Karsenty G and Wagner EF: Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2:389–406. 2002. View Article : Google Scholar : PubMed/NCBI
3	Theill LE, Boyle WJ and Penninger JM: RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 20:795–823. 2002. View Article : Google Scholar : PubMed/NCBI
4	Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J and Choi Y: Osteoimmunology: Interplay between the immune system and bone metabolism. Annu Rev Immunol. 24:33–63. 2006. View Article : Google Scholar : PubMed/NCBI
5	Binder NB, Niederreiter B, Hoffmann O, Stange R, Pap T, Stulnig TM, Mack M, Erben RG, Smolen JS and Redlich K: Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat Med. 15:417–424. 2009. View Article : Google Scholar : PubMed/NCBI
6	Fata JE, Kong YY, Li J, Sasaki T, Irie-Sasaki J, Moorehead RA, Elliott R, Scully S, Voura EB, Lacey DL, et al: The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell. 103:41–50. 2000. View Article : Google Scholar : PubMed/NCBI
7	Fuller K, Wong B, Fox S, Choi Y and Chambers TJ: TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med. 188:997–1001. 1998. View Article : Google Scholar : PubMed/NCBI
8	Boyle WJ, Simonet WS and Lacey DL: Osteoclast differentiation and activation. Nature. 423:337–342. 2003. View Article : Google Scholar : PubMed/NCBI
9	Teitelbaum SL and Ross FP: Genetic regulation of osteoclast development and function. Nat Rev Genet. 4:638–649. 2003. View Article : Google Scholar : PubMed/NCBI
10	Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, et al: Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 3:889–901. 2002. View Article : Google Scholar : PubMed/NCBI
11	Zhou P, Sun LJ, Dötsch V, Wagner G and Verdine GL: Solution structure of the core NFATC1/DNA complex. Cell. 92:687–696. 1998. View Article : Google Scholar : PubMed/NCBI
12	Na KL: Molecular understanding of osteoclast differentiation and physiology. J Clin Endocr Metab. 25:264–269. 2010.
13	Ishida N, Hayashi K, Hattori A, Yogo K, Kimura T and Takeya T: CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration. J Bone Miner Res. 21:48–57. 2006. View Article : Google Scholar
14	Soriano P, Montgomery C, Geske R and Bradley A: Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 64:693–702. 1991. View Article : Google Scholar : PubMed/NCBI
15	Lakkakorpi PT, Nakamura I, Young M, Lipfert L, Rodan GA and Duong LT: Abnormal localisation and hyperclustering of alpha (v)beta (3) integrins and associated proteins in Src-deficient or tyrphostin A9-treated osteoclasts. J Cell Sci. 114:149–160. 2001.
16	Chen J, He JQ, Zheng SY and Huang LQ: OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell. Rheumatol Int. 32:3393–3398. 2012. View Article : Google Scholar
17	Chen J and He CQ, Xia QJ, Huang LQ, Hu YJ and He CQ: Effects of pulsed electromagnetic fields on the mRNA expression of RANK and CAII in ovariectomized rat osteoclast-like cell. Connect Tissue Res. 51:1–7. 2010. View Article : Google Scholar : PubMed/NCBI
18	Pavlos NJ, Xu J, Riedel D, Yeoh JS, Teitelbaum SL, Papadimitriou JM, Jahn R, Ross FP and Zheng MH: Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption. Mol Cell Biol. 25:5253–5269. 2005. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
20	Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM and Suda T: Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med. 190:1741–1754. 1999. View Article : Google Scholar : PubMed/NCBI
21	Crotti T, Smith MD, Hirsch R, Soukoulis S, Weedon H, Capone M, Ahern MJ and Haynes D: Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res. 38:380–387. 2003. View Article : Google Scholar : PubMed/NCBI
22	Crotti TN, Smith MD, Findlay DM, Zreiqat H, Ahern MJ, Weedon H, Hatzinikolous G, Capone M, Holding C and Haynes DR: Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: Expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. Biomaterials. 25:565–573. 2004. View Article : Google Scholar
23	Crotti TN, Smith MD, Weedon H, Ahern MJ, Findlay DM, Kraan M, Tak PP and Haynes DR: Receptor activator NF-kappa B ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: Semiquantitative and quantitative analysis. Ann Rheum Dis. 61:1047–1054. 2002. View Article : Google Scholar : PubMed/NCBI
24	Hirotani H, Tuohy NA, Woo JT, Stern PH and Clipstone NA: The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem. 279:13984–13992. 2004. View Article : Google Scholar : PubMed/NCBI
25	Thomas SM and Brugge JS: Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 13:513–609. 1997. View Article : Google Scholar : PubMed/NCBI
26	Kumagai N, Ohno K, Tameshige R, Hoshijima M, Yogo K, Ishida N and Takeya T: Induction of mouse c-src in RAW264 cells is dependent on AP-1 and NF-kappaB and important for progression to multinucleated cell formation. Biochem Biophys Res Commun. 325:758–768. 2004. View Article : Google Scholar : PubMed/NCBI
27	Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR and Soriano P: Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA. 90:4485–4489. 1993. View Article : Google Scholar : PubMed/NCBI
28	Boyce BF, Yoneda T, Lowe C, Soriano P and Mundy GR: Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest. 90:1622–1627. 1992. View Article : Google Scholar : PubMed/NCBI